Delivery Order SPE2DB24D1205-SPE2DB24FCRXW
Award Date
6/10/24
Potential Completion Date
6/11/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The $12,666.27 Firm Fixed Price Delivery Order was awarded on May 23, 2024 by the Defense Logistics Agency (DLA), with an ultimate completion date of May 24, 2024. The contract is not set-aside.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The $11,293.37 firm fixed price delivery order was awarded on May 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 29, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The $16,034.74 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024.
Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,379.80 firm fixed price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 31, 2024 and is not designated as a set-aside.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML to the Defense Logistics Agency (DLA). The $49,201.86 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceuticals and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The $8,557.75 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 20, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML to the Defense Logistics Agency (DLA). The contract, valued at $13,218.80, has a firm fixed price and an ultimate completion date of June 26, 2024. This is a delivery order contract and does not have a set-aside designation.
Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML to the Defense Logistics Agency (DLA). The $3,304.72 Firm Fixed Price Delivery Order has a completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DUPIXENT 200 MG/1.14 ML PEN 1.14ML. The contract, valued at $29,100.36, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 18, 2024, with a completion date of June 20, 2024.
Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, involves the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $22,457.04 firm fixed price delivery order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The company also holds an indefinite delivery...